Skip to main content
Loren Mell, MD, Radiation Oncology, La Jolla, CA, Jennifer Moreno Department of Veterans Affairs Medical Center

LorenK.MellMD

Radiation Oncology La Jolla, CA

Gynecologic Cancer, Head & Neck

Professor of Radiation Medicine Vice Chair, Clinical and Translational Research Director, Center for Precision Radiation Medicine UC San Diego Medical Center

Dr. Mell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mell's full profile

Already have an account?

Summary

  • Dr. Loren Mell is a radiation oncologist in La Jolla, CA and is affiliated with multiple hospitals in the area, including VA San Diego Healthcare System and UC San Diego Health. He received his medical degree from University of Chicago Pritzker School of Medicine and has been in practice 14 years. He specializes in gynecologic cancer and head & neck and is experienced in image-guided radiation therapy.

Education & Training

  • University of Chicago/University of Illinois College of Medicine at Chicago
    University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2004 - 2008
  • Ascension Illinois/Resurrection
    Ascension Illinois/ResurrectionInternship, Transitional Year, 2003 - 2004
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - 2024
  • IL State Medical License
    IL State Medical License 2003 - 2008
  • American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • ‘Optimism Bias’ in Contemporary National Clinical Trial Network Phase III Trials: Are We Improving?  
    S S Noticewala, L K Mell, Annals of Oncology

Lectures

  • Safety of radiotherapy with concurrent and adjuvant MEDI4736 (durvalumab) in patients with locoregionally advanced head and neck cancer with a contraindication to cisp... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Adding Docetaxel to RT Improves Survival in Cisplatin-Ineligible Head & Neck Cancer
    Adding Docetaxel to RT Improves Survival in Cisplatin-Ineligible Head & Neck CancerFebruary 3rd, 2023
  • The Prostate Cancer Foundation Announces 2020 Young Investigator Awards Totaling $6 Million for Prostate Cancer Research
    The Prostate Cancer Foundation Announces 2020 Young Investigator Awards Totaling $6 Million for Prostate Cancer ResearchDecember 16th, 2020
  • Expert Calls for a Change in the Staging of HNSCC
    Expert Calls for a Change in the Staging of HNSCCNovember 20th, 2017
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations